118 related articles for article (PubMed ID: 3383944)
1. Phase II study of estramustine phosphate (Estracyt) in patients with metastatic melanoma.
Jönsson PE; Ingvar C; Fernö M; Hafström L; Rudenstam CM
Eur J Cancer Clin Oncol; 1988 Mar; 24(3):413-5. PubMed ID: 3383944
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor and binding site for estramustine in metastatic malignant melanoma.
Fernö M; Borg A; Ingvar C; Jönsson PE
Anticancer Res; 1987; 7(4B):741-3. PubMed ID: 3314674
[TBL] [Abstract][Full Text] [Related]
3. Estramustine binding site in human breast cancer biopsy samples. Its relation to estrogen and progesterone receptor levels, age and menopausal status.
Fernö M; Borg A; Idvall I
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1505-10. PubMed ID: 3678314
[TBL] [Abstract][Full Text] [Related]
4. Estramustine phosphate in the treatment of advanced malignant melanoma.
Lopez R; Karakousis CP; Didolkar MS; Holyoke ED
Cancer Treat Rep; 1978 Sep; 62(9):1329-32. PubMed ID: 688276
[TBL] [Abstract][Full Text] [Related]
5. Oral estramustine phosphate (Estracyt): a broad phase II study.
Halpern J; Catane R
J Med; 1984; 15(1):35-43. PubMed ID: 6593404
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers].
Wada T; Morikawa E; Houjou T; Kadota K; Mori N; Matsunami N; Watatani M; Yasutomi M
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1901-4. PubMed ID: 2393306
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
[No Abstract] [Full Text] [Related]
9. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
Chisholm GD; O'Donoghue EP; Kennedy CL
Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
[TBL] [Abstract][Full Text] [Related]
10. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
Balogh F; Kisbenedek L
Int Urol Nephrol; 1975; 7(2):135-40. PubMed ID: 1102475
[TBL] [Abstract][Full Text] [Related]
11. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
Slack NH; Wajsman Z; Mittelman A; Bruno S; Murphy GP
Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
[TBL] [Abstract][Full Text] [Related]
12. Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer.
Boccardo F; Decensi A; Guarneri D; Martorana G; Giberti C; Giuliani L
Cancer Chemother Pharmacol; 1988; 22(2):172-4. PubMed ID: 3409448
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG.
Karakousis CP; Emrich LJ
J Surg Oncol; 1987 Dec; 36(4):235-8. PubMed ID: 3695527
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
[TBL] [Abstract][Full Text] [Related]
15. Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
Könyves I
Int Urol Nephrol; 1989; 21(4):393-7. PubMed ID: 2693392
[TBL] [Abstract][Full Text] [Related]
16. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
Benson RC
Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
[No Abstract] [Full Text] [Related]
17. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
Jönsson G; Högberg B; Nilsson T
Scand J Urol Nephrol; 1977; 11(3):231-8. PubMed ID: 339329
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
Trykker HU
Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
[No Abstract] [Full Text] [Related]
19. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
Fritjofsson A; Norlén BJ; Högberg B; Rajalakshmi M; Cekan SZ; Diczfalusy E
Scand J Urol Nephrol; 1981; 15(1):37-44. PubMed ID: 6787701
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
Stridsklev IC; Fosså SD; Kaalhus O
Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
